<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-16T21:27:55+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>医保谈判DAY3：恒瑞PD-1大降超80%，4个适应证全进医保，K药、O药没进？</title>
    <updated>2020-12-16T19:24:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/-0RqOiY_AGcnTD7q89WulQ</id>
    <link href="https://mp.weixin.qq.com/s/-0RqOiY_AGcnTD7q89WulQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产创新药爆发：重大新药创制已有60款本土药获批！但创新还有这些挑战！</title>
    <updated>2020-12-16T19:24:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/L7OCUkoN7I96XrJu7uYsKg</id>
    <link href="https://mp.weixin.qq.com/s/L7OCUkoN7I96XrJu7uYsKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【中国中药65周年】倒计时3天！您将见证一场来自中药行业的云盛会！</title>
    <updated>2020-12-16T19:24:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/Cvawza10JpwSDjG4c08B0g</id>
    <link href="https://mp.weixin.qq.com/s/Cvawza10JpwSDjG4c08B0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判DAY2：AZ、杨森、再鼎已至。PD-1谈判前，恒瑞再破5000亿，百济、君实皆涨</title>
    <updated>2020-12-15T21:44:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/KE9W3GuQ05MmRrWqtg1dkw</id>
    <link href="https://mp.weixin.qq.com/s/KE9W3GuQ05MmRrWqtg1dkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代伟大中国创新药企长什么样？</title>
    <updated>2020-12-15T21:44:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ZTL-xsn8tcmhiUR0SwN8bg</id>
    <link href="https://mp.weixin.qq.com/s/ZTL-xsn8tcmhiUR0SwN8bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>打开获批20个适应证的8个PD-(L)1的正确方式</title>
    <updated>2020-12-15T21:44:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ntNnGuCaXQFG8_pLJv6hOQ</id>
    <link href="https://mp.weixin.qq.com/s/ntNnGuCaXQFG8_pLJv6hOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判DAY1：降幅超预期，多为独家品种，涉诺华、礼来。PD-1或在第三天</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/2rhvxukVFpLpVgdchHt9Vw</id>
    <link href="https://mp.weixin.qq.com/s/2rhvxukVFpLpVgdchHt9Vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访亚盛医药首席商务运营官祝刚：港股原创小分子第一股的商业经</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/SPvSVI_7vJQAm0D3M9f9cg</id>
    <link href="https://mp.weixin.qq.com/s/SPvSVI_7vJQAm0D3M9f9cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>氟唑帕利的前世今生——恒瑞医药李心博士专访</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/ScEkC5MQHvMvy81FT3JEmw</id>
    <link href="https://mp.weixin.qq.com/s/ScEkC5MQHvMvy81FT3JEmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>聚产业力量，创产业未来 ——中国医药产业链首个品牌服务商联盟发起成立</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/FomOK7F5AfxYIssUPBPrWQ</id>
    <link href="https://mp.weixin.qq.com/s/FomOK7F5AfxYIssUPBPrWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康豪掷2500亿拟收购罕见病巨头，今年最大收购！</title>
    <updated>2020-12-13T20:48:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/pVNd4NBAno7zFPOMa8jq7g</id>
    <link href="https://mp.weixin.qq.com/s/pVNd4NBAno7zFPOMa8jq7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3800亿市值京东健康，来看看10万亿的亚马逊如何布局医药健康！</title>
    <updated>2020-12-13T20:48:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/vbBj1ryM4zgl5SgvX6KBLA</id>
    <link href="https://mp.weixin.qq.com/s/vbBj1ryM4zgl5SgvX6KBLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年创新药热门靶点盘点！谁是下个PD-(L)1？谁能颠覆目前格局？</title>
    <updated>2020-12-12T19:05:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/nUSGzszhisAUcAki9nSz8w</id>
    <link href="https://mp.weixin.qq.com/s/nUSGzszhisAUcAki9nSz8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>单笔融资超3亿美元！AI+药物研发迎来新拐点？</title>
    <updated>2020-12-12T19:05:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/E6og76sUFKrDZhZBDpEzMg</id>
    <link href="https://mp.weixin.qq.com/s/E6og76sUFKrDZhZBDpEzMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康与艾德生物携手推进县域肿瘤精准诊疗 惠及基层医患</title>
    <updated>2020-12-12T19:05:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/3N2OCUN2EXmgoJTFjjB_rw</id>
    <link href="https://mp.weixin.qq.com/s/3N2OCUN2EXmgoJTFjjB_rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞第七款创新药获批在即，直面百济、再鼎与AZ！进击全球TOP15！</title>
    <updated>2020-12-11T17:35:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/G-mwe2waksBbmg7HuUeWkw</id>
    <link href="https://mp.weixin.qq.com/s/G-mwe2waksBbmg7HuUeWkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>日本媒体眼中的中国集采和“败”下阵来的卫材、参天、科研</title>
    <updated>2020-12-11T17:35:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/V6m1Bwx1dJZLcWBg0N3T5Q</id>
    <link href="https://mp.weixin.qq.com/s/V6m1Bwx1dJZLcWBg0N3T5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保局考虑把更多罕见病用药纳入集采，涉及杨森、诺和诺德等数十亿美元品种！</title>
    <updated>2020-12-11T17:35:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/QwOKNbk4QTd0yx9pZQTCeA</id>
    <link href="https://mp.weixin.qq.com/s/QwOKNbk4QTd0yx9pZQTCeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研发30年，致敬诺奖级肿瘤疗法！</title>
    <updated>2020-12-10T21:38:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/-JcW3DGzwwNFEvYayt3W4w</id>
    <link href="https://mp.weixin.qq.com/s/-JcW3DGzwwNFEvYayt3W4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批集采：44品种，谁竞争最激烈？谁价格最低？谁市场最大？谁最波折？替格瑞洛为何二次进集采？</title>
    <updated>2020-12-10T21:38:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/9yH2QXT9ln8Ie5eBB0ftUQ</id>
    <link href="https://mp.weixin.qq.com/s/9yH2QXT9ln8Ie5eBB0ftUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>